Pituitary Adenoma and Serum Lipid
Pituitary Adenoma and Serum Lipid
Pituitary adenomas are usually benign monoclonal neoplasms caused by a mixture of pituicyte
 alterations together with a changed endocrine and paracrine regulatory milieu. Thus, it can
 cause serious health problems such as abnormal target organ function, pain, disability and
 even death. In clinical practice, we found many patients with pituitary adenomas are usually
 accompanied by hyperlipidemia, which is the main cause of cardiovascular diseases. However,
 it has been unclear if there is an association between pituitary adenomas and serum lipid
 profile. In the present study, we aim to focus on the patients with pituitary adenomas and
 their lipid profile before and after operation including first occurrence and recurrence.
Inclusion Criteria:

 1. Patients diagnosed with pituitary adenomas

 2. All adenomas were resected by transsphenoidal surgery and identified by histological
 diagnoses.

 Exclusion Criteria:

 1. Missing vital data, such as age, gender, serum lipid profile, pathology reports;

 2. Complications or conditions that affect pituitary status and lipid metabolism, such as
 pregnancy, malignant adenomas or severe hepatic or renal dysfunction and

 3. Use of any medication that affects the pituitary or lipid metabolism, including
 statins, fibrates, thyroid hormones, anti-thyroid drugs, iodine, amiodarone,
 alemtuzumab, lithium, tyrosine kinase inhibitors, interferon, estrogens,
 androgens,glucocorticoids, nonsteroidal anti-inflammatory drugs, antiepileptic drugs,
 rifampicin, furosemide, heparin or β-adrenoceptor blockers in the past 3 months.